Merus merus.nl


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, referred to as Biclonics. Biclonics are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have several of the same features of conventional IgG-based antibodies, such as long half-life and low immunogenicity. Merus's lead Biclonics product candidate, MCLA-128 is being evaluated in a Phase 1/2 clinical tria...Show all

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, referred to as Biclonics. Biclonics are based on the full-length IgG format, are manufactured using industry standard processes and have been ob...Show all

Company (IPO / Went public)

Phone: +31 (0)30 253 8800

Fax:

Padualaan 8

Utrecht, 3584 CH
Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Merus $145.5M Jan 19, 2021
HNC Software $0M May 2, 2002
Cardiac Pathways $67M Aug 10, 2001
See all 27 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Merus Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors

Competitors

Company Status Description Investors
See all 27 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Recombinant production of mixtures of antibodies Apr 04, 2016 Mar 02, 2021 Patent
Antibodies that bind egfr and erbb3 Feb 27, 2015 Nov 24, 2020 Patent
Methods and means for the production of ig-like molecules May 20, 2019 Aug 25, 2020 Patent
Method for selecting a single cell expressing a heterogeneous combination of antibodies Aug 21, 2017 Jun 02, 2020 Patent
Generation of binding molecules Nov 22, 2017 May 12, 2020 Patent
See all 60 patents